NASDAQ: BIIB · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Biogen Inc.

How Biogen Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$36.9B

Price

$249.65

P/E

106.2

EPS (TTM)

$2.35

1-year return

66.9%

Dividend yield

0.0%

52-week range

$149.33–$253.84

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector
• S&P 500

For information only, not investment advice. Data may contain errors. Disclaimer · Sources